Labcorp price target raised to $260 from $240 at Piper Sandler
Piper Sandler raised the firm’s price target on Labcorp (LH) to $260 from $240 following quarterly results. The firm keeps a Neutral rating on ...
Labcorp price target raised to $248 from $231 at Deutsche Bank
Deutsche Bank analyst Pito Chickering raised the firm’s price target on Labcorp (LH) to $248 from $231 and keeps a Hold rating on the shares ...
Jefferies raises LabCorp stock price target to $290
Jefferies analyst Tycho Peterson updated the financial outlook for Laboratory Corporation of America (NYSE:LH), increasing the price target to $290 from $275 while maintaining a Buy rating on the ...
Labcorp targets 2025 EPS growth of up to 10% with expanding margins
Q4 2024 Management View Labcorp reported revenue of $3.3 billion for Q4 2024, an increase of 10% year-over-year, with Diagnostics and Biopharma segments each posting 10% growth. Chairman and CEO Adam ...
Labcorp's Narrow Economic Moat Remains Solid
The more complex and labor-intensive esoteric tests are reimbursed at a higher rate and often outsourced by hospitals to independent labs. Labcorp is funneling resources to broaden its menu of complex ...
360dx1mon
JP Morgan Healthcare Conference, Day 2: Thermo Fisher, Labcorp, Hologic, CareDx, More
Laboratory Corporation of America sees acquisitions and esoteric testing as key growth drivers, Adam Schechter, the company's chairman, president, and CEO, said during a fireside chat here. During the ...
Becker's Hospital Review1mon
Labcorp to manage NJ system's lab operations
Labcorp will also serve as the primary lab for Inspira's physician network. "This strategic relationship enables Inspira Health to leverage Labcorp’s leading clinical laboratory services and ...